Anti-Integrin beta 5 Purified

Also known as: Integrin b5, ITGB5

Clone: KN52

RUO: For Research Use Only. Not for use in diagnostic procedures.

SKU# 14-0497

Cat. No. Size
14-0497-80 25 ug
14-0497-82 100 ug

To enable ordering, please select your country. Cookies will need to be enabled to continue on our website. View our Privacy Policy.

Data for Anti-Integrin beta 5 Purified.

Click on image to view more information.

More Views

  • Data for Anti-Integrin beta 5 Purified.
Description

Description: The KN52 antibody reacts with human integrin beta 5, an approximately 100,000 Mr (reduced) and 95,000 Mr (nonreduced) a member of the integrin family. Only a single alpha chain, the alpha v subunit, associates with the integrin beta 5 to form the vitronectin receptor complex. Integrin alpha v/beta 5 complex also binds to the basic domain of Tat (he sequence RKKRRQRRR). The integrin beta 5 is found on carcinoma cell lines, hepatoma and fibroblast cell lines, and is absent from lymphoblastoid cells and platelets.

The KN52 monoclonal antibody has been shown to inhibit migration.

Details
Host Mouse
Isotype IgG1, kappa
Reactivity Hamster, Human, Mouse
Conjugate Purified
Reported Applications Flow Cytometric Analysis, Functional Assays
Documentation

For complete product information, please download the TDS or IFU document.

TDS Link Download TDS
Additional Formats
Cat. No. Name Excite Emit Application Reg.
12-0497 Anti-Integrin beta 5 PE 488 nm 575 nm FC RUO
11-0497 Anti-Integrin beta 5 FITC 488 nm 518 nm FC RUO
16-0497 Anti-Integrin beta 5 Functional Grade Purified FC, FA RUO
References

References: Sangaletti S, Di Carlo E, Gariboldi S, Miotti S, Cappetti B, Parenza M, Rumio C, Brekken RA, Chiodoni C, Colombo MP. Macrophage-derived SPARC bridges tumor cell-extracellular matrix interactions toward metastasis. Cancer Res. 2008 Nov 1;68(21):9050-9. (KN52, FA, PubMed)

Lai CF, Feng X, Nishimura R, Teitelbaum SL, Avioli LV, Ross FP, Cheng SL. Transforming growth factor-beta up-regulates the beta 5 integrin subunit expression via Sp1 and Smad signaling. J Biol Chem. 2000 Nov 17;275(46):36400-6.

Sugiyama M, Speight PM, Prime SS, Watt FM. Comparison of integrin expression and terminal differentiation capacity in cell lines derived from oral squamous cell carcinomas. Carcinogenesis. 1993 Oct;14(10):2171-6.


View More Products

AntigensArea of BiologyFormats